Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : JNJ crawled time : 23:00 save search
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
ARDX | News | $6.445 -1.6% -1.63% 3.5M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
report million treatment antibiotics global market
FDA Approves Potential 'Game Changer' for Pulmonary Arterial Hypertension
Published: 2024-03-26 (Crawled : 23:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
fda hypertension potential
U.S. FDA Approves OPSYNVI® (macitentan and tadalafil) as the First and Only Once-Daily Single-Tablet Combination Therapy for Patients with Pulmonary Arterial Hypertension (PAH)
Published: 2024-03-22 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
opsynvi fda first hypertension therapy
Global Subcutaneous Immunoglobulin Market Analysis & Forecast 2024-2034, By Product, Application, End-user and Region
Published: 2024-03-21 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.36%
C: -0.31%
global market
INSTITUTE FOR SUPPLY MANAGEMENT® HONORS 30 UNDER 30 RISING SUPPLY CHAIN STARS
Published: 2024-03-20 (Crawled : 23:00) - prnewswire.com
X | $38.94 -0.49% 0.1% 3.3M
|
Non-Energy Minerals
|
| O: 0.1%
H: 0.97%
C: 0.81%
NOC | News | $452.5 0.1% 0.74% 820K
|
Electronic Technology
|
| O: 0.25%
H: 0.34%
C: -0.94%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
FLR | $39.21 -0.99% -1.48% 1.1M
|
Industrial Services
|
| O: 0.86%
H: 2.89%
C: 2.82%
management institute stars
FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.33%
H: 0.13%
C: -1.51%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.71%
H: 0.36%
C: -2.52%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
fda rare first disease therapy
Register Now for the 7th Annual Digi-Tech Pharma & AI Conference: London, United Kingdom - May 28-29, 2024
Published: 2024-03-15 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
pharma
FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma
Published: 2024-03-15 (Crawled : 23:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
fda
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 2.01%
H: 0.0%
C: -2.01%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.79%
C: 0.79%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.19%
H: 0.22%
C: -0.21%
global set growth market
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
Published: 2024-03-01 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
hospital pharmaceuticals global medical trial
Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024: PRMT5 Targeted Therapies Clinical Trials by Company, Indication & Phase
Published: 2024-02-28 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
trials global therapy market
TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myeloma
Published: 2024-02-20 (Crawled : 23:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
tecvayli fda approved treatment
Global Hemostats Market Research Report 2023-2028 with Competitive Analysis of Leading Players - Johnson & Johnson, Baxter International, Pfizer, B. Braun, and Becton, Dickinson and Co
Published: 2024-02-20 (Crawled : 23:00) - prnewswire.com
TFX | News | $207.38 -0.44% 0.0% 150K
|
Health Technology
|
| O: 0.16%
H: 0.48%
C: -0.16%
SYK | $327.45 -2.55% 0.0% 2.1M
|
Health Technology
|
| O: 0.24%
H: 0.39%
C: -0.38%
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -0.73%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: 0.03%
H: 1.99%
C: 1.91%
report research global market
Global Plastic Resin Market Size, Share & Trends Analysis Report 2024-2030: Advent of Bio-Based Plastic Resins has Played a Prominent Role in Food and Beverage, and Pharmaceutical Applications
Published: 2024-02-20 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
EMN | $96.02 0.05% 0.0% 680K
|
Process Industries
|
| O: -0.17%
H: 1.77%
C: 1.59%
DOW | News A | $56.49 -0.58% -0.02% 3.8M
|
Process Industries
|
| O: 0.24%
H: 1.81%
C: 1.66%
report food global trends market
North America Sheet Metal Fabrication Equipment Market Analysis Report 2024-2030, Featuring Trumpf, Bystronic Laser, Winbro, Mazak, WARDJet, Omax, Salvagnini and Flow International
Published: 2024-02-20 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
america report international flow market
Global Intraocular Lens Market Report 2024: Market to Grow from $4.23 Billion in 2023 to $6.11 Billion by 2030 - Rising Incidence of Myopia and Diabetes Boosts Demand
Published: 2024-02-16 (Crawled : 23:00) - prnewswire.com
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
| Email alert
Add to watchlist
ALC | $78.47 -0.67% -0.01% 760K
|
Health Technology
| Email alert
Add to watchlist
STAA | $46.79 0.97% 0.96% 380K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
report global diabetes market
FDA Decisions: Novartis and Roche Win Multiple-Allergy Indication for Xolair
Published: 2024-02-16 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: -0.37%
H: 0.81%
C: -0.65%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
fda xolair novartis roche
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $17.112 -17.59% 1.5K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -3.21%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.04%
TRUMY | $16.69 0.79% 54K
|
Manufacturing
|
| O: 0.27%
H: 0.0%
C: -2.6%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.37%
H: 0.57%
C: 0.19%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
drug patent report review global advanced market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | News | $14.2 3.5% 3.38% 690K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $358.65 -2.06% -2.11% 240K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
New England Journal of Medicine Publishes Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113 in a Phase 2b Moderate-To-Severe Plaque Psoriasis Study
Published: 2024-02-07 (Crawled : 23:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: 0.0%
PTGX | $25.23 -1.33% -1.35% 390K
|
Health Technology
|
| O: -0.23%
H: 0.54%
C: -1.13%
jnj-2113 psoriasis study
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.